Structure and promoter analysis of the gene encoding the human melanoma-inhibiting protein MIA
about
Structure of melanoma inhibitory activity protein, a member of a recently identified family of secreted proteinsUpregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotypeFunctional role of MIA in melanocytes and early development of melanomaFdp, a new fibrocyte-derived protein related to MIA/CD-RAP, has an in vitro effect on the early differentiation of the inner ear mesenchymeUltrastructural cartilage abnormalities in MIA/CD-RAP-deficient miceDetailed analysis of MIA protein by mutagenesis.Melanoma inhibitory activity (MIA): an important molecule in melanoma development and progression.Diagnostic and prognostic biomarkers in melanoma.Serological markers for melanoma.Specific expression and regulation of the new melanoma inhibitory activity-related gene MIA2 in hepatocytes.Targeting melanoma metastasis and immunosuppression with a new mode of melanoma inhibitory activity (MIA) protein inhibition.New prognostic factors of cutaneous melanoma: a review of the literature.Evidence for secretory pathway localization of a voltage-dependent anion channel isoformPromoters with cancer cell-specific activity for melanoma gene therapy.Melanoma biomarkers: Vox clamantis in deserto (Review)Cutaneous melanoma: baseline and ongoing laboratory evaluation.Mouse CD-RAP/MIA gene: structure, chromosomal localization, and expression in cartilage and chondrosarcoma.Biomarkers in melanoma.Non-histone nuclear factor HMGB1 as a therapeutic target in colorectal cancer.Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail.Human melanoma inhibitory protein binds to the FN12-14 Hep II domain of fibronectin.Gene therapy for advanced melanoma: selective targeting and therapeutic nucleic acids.MIA (melanoma inhibitory activity) promoter mediated tissue-specific suicide gene therapy of malignant melanoma.Evaluation of combined gene regulatory elements for transcriptional targeting of suicide gene expression to malignant melanoma.Active detachment involves inhibition of cell-matrix contacts of malignant melanoma cells by secretion of melanoma inhibitory activity.Regulation of the mouse cartilage-derived retinoic acid-sensitive protein gene by the transcription factor AP-2.Regulatory pathway analysis of coat color genes in Mongolian horses.In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancers.Melanoma-inhibiting activity (MIA) mRNA is not exclusively transcribed in melanoma cells: low levels of MIA mRNA are present in various cell types and in peripheral blood.Adaptation of commercial immunoassays to analysis of complex biological substances.Regulation of integrin activity by MIA.Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma.Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma.
P2860
Q24598268-11A9F3EA-496E-4927-9C2D-EA307D632322Q24685044-570D0D87-26AA-46A2-9D8D-3D83F9D9238CQ28267890-998BB5DF-A33A-4FD0-882C-346A66E10A2FQ28591745-0DD0DCE2-BA7D-403A-AACC-A3B698A14BAAQ28591920-85FCFD52-E381-4D42-99EC-6386D08A884FQ30159544-26BF717C-26C2-49DE-9660-04ECBA6471A9Q30351793-EBCA55C8-7660-4875-A3A1-D0441C57264FQ33862470-12B36B48-4732-496D-8E4E-DD7FA30C0FE5Q34010092-B1FFEA9F-C277-492A-9D4D-BF77ECC7D10AQ34177232-01C5B263-4989-448B-B2AD-A76954FA661FQ34292719-64FA54A3-6246-4024-BA2E-05476B4BB90AQ34756424-2DE3B092-BF07-47F6-A5A1-BBDBB92F3C4FQ35107726-71B788CA-C76C-4725-94E1-1854AB5B28ABQ35944371-B54E7E3C-2D05-4BBD-AA9E-91E7CFF9774EQ36216949-E0AD54F2-D6A9-4282-9C6F-39678B805917Q36317101-45EDB403-2976-422D-955C-E41C6FC15EF7Q36853053-6BBE2C45-1863-4303-9736-327573758B87Q37555801-67241C23-C9C9-4A1B-8E43-A46C862E14DBQ37825897-4A8C96F7-E35B-480E-A3CF-81452382B096Q38301455-BCDB3681-E634-41E7-86DE-C16DE607D437Q38676582-C26DB416-434B-4E6F-9460-8BAD2EAD2188Q39672404-8A5F26CB-FBA0-4E0C-9D67-68AE9F45F896Q40561045-91793520-639B-4A73-836D-A21EADBBA97DQ40600863-A202F85A-A2B8-4B4C-B0B9-2C23E9A63CCFQ40616648-E22775DA-76B6-4CD4-A647-1B431C70C323Q41056253-5FC9F17F-8D3C-41DF-8FC9-D4368352929BQ41767294-E4712787-B87A-4ED7-BDB6-D21EF0D28C67Q42474412-BCC7C671-05DC-4FD0-AD4A-B34D049A6FFCQ43201983-244D50FF-A53F-450D-BF9F-287AF02FC74DQ43888517-6931B568-7E00-43AC-987F-EF106705BCEDQ46975937-E804D511-B0EC-4782-B92D-A78F2AE7DD6FQ54646259-1175510C-5CDE-4518-8F18-6F34C7AC8D91Q54700942-9B24BB2C-7446-4CC6-92F9-E860971AE4A1
P2860
Structure and promoter analysis of the gene encoding the human melanoma-inhibiting protein MIA
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Structure and promoter analysi ...... elanoma-inhibiting protein MIA
@ast
Structure and promoter analysi ...... elanoma-inhibiting protein MIA
@en
Structure and promoter analysi ...... elanoma-inhibiting protein MIA
@nl
type
label
Structure and promoter analysi ...... elanoma-inhibiting protein MIA
@ast
Structure and promoter analysi ...... elanoma-inhibiting protein MIA
@en
Structure and promoter analysi ...... elanoma-inhibiting protein MIA
@nl
prefLabel
Structure and promoter analysi ...... elanoma-inhibiting protein MIA
@ast
Structure and promoter analysi ...... elanoma-inhibiting protein MIA
@en
Structure and promoter analysi ...... elanoma-inhibiting protein MIA
@nl
P2093
P2860
P356
P1476
Structure and promoter analysi ...... elanoma-inhibiting protein MIA
@en
P2093
P2860
P356
10.1074/JBC.271.1.490
P407
P577
1996-01-05T00:00:00Z